|
Medicamen Organics Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
48.91 Cr.
|
P/BV
|
1.66
|
Book Value (Rs.)
|
25.11
|
|
52 Week High/Low (Rs.)
|
128/20
|
FV/ML
|
10/2000
|
P/E(X)
|
12.08
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
3.46
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | PR |
| FaceValue | 10.00 | 10.00 |
| | | |
| PER SHARE RATIOS | | |
| | | |
| Basic EPS (Rs.) | 3.67 | 3.47 |
| Diluted EPS (Rs.) | 3.66 | 3.47 |
| Cash EPS (Rs.) | 4.09 | 3.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 25.75 | 17.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 25.75 | 17.74 |
| Revenue From Operations / Share (Rs.) | 32.64 | 29.39 |
| PBDIT / Share (Rs.) | 5.71 | 5.53 |
| PBIT / Share (Rs.) | 5.08 | 4.69 |
| PBT / Share (Rs.) | 4.64 | 5.16 |
| Net Profit / Share (Rs.) | 3.46 | 3.05 |
| NP After MI And SOA / Share (Rs.) | 3.46 | 3.05 |
| | | |
| PROFITABILITY RATIOS | | |
| | | |
| PBDIT Margin (%) | 17.49 | 18.81 |
| PBIT Margin (%) | 15.56 | 15.97 |
| PBT Margin (%) | 14.22 | 17.55 |
| Net Profit Margin (%) | 10.59 | 10.38 |
| NP After MI And SOA Margin (%) | 10.59 | 10.38 |
| Return on Networth / Equity (%) | 13.43 | 17.19 |
| Return on Capital Employeed (%) | 18.54 | 23.99 |
| Return On Assets (%) | 6.83 | 6.82 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.41 | 0.82 |
| | | |
| LIQUIDITY RATIOS | | |
| | | |
| Current Ratio (X) | 1.67 | 1.26 |
| Quick Ratio (X) | 1.40 | 0.97 |
| | | |
| COVERAGE RATIOS | | |
| | | |
| Interest Coverage Ratio (%) | 13.01 | 7.35 |
| Interest Coverage Ratio (Post Tax) (%) | 8.88 | 3.43 |
| | | |
| VALUATION RATIOS | | |
| | | |
| Enterprise Value (Cr.) | 33.96 | 0.00 |
| EV / Net Operating Revenue (X) | 0.88 | 0.00 |
| EV / EBITDA (X) | 5.08 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 0.00 |
| Price / BV (X) | 0.84 | 0.00 |
| Price / Net Operating Revenue (X) | 0.66 | 0.00 |
| EarningsYield | 0.15 | 0.00 |
